Actively Recruiting

Age: 0 - 11Years
FEMALE
NCT05299710

Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)

Led by Erin Rowell · Updated on 2024-11-18

250

Participants Needed

1

Research Sites

865 weeks

Total Duration

On this page

Sponsors

E

Erin Rowell

Lead Sponsor

A

Ann & Robert H Lurie Children's Hospital of Chicago

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to safely remove ovarian tissue in pre-pubertal pediatric patients, who are at risk for infertility from their medical treatment, for freezing for future restoration of fertility and hormone function.

CONDITIONS

Official Title

Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)

Who Can Participate

Age: 0 - 11Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Pre- Pubertal Individual
  • Will undergo imminent surgery, chemotherapy or radiation therapy that has implications on future fertility and reproductive hormone potential: any health condition or malignancy that requires removal of all or part of one or both ovaries, whole abdomen or pelvic irradiation ≥10Gy in post-pubertal girls or ≥15Gy in pre-pubertal girls total body irradiation, and alkylating-intensive chemotherapy:
  • cyclophosphamide cumulative dose ≥7.5 g/m2
  • any treatment regimen containing procarbazine
  • busulfan cumulative dose >600 mg/m2
  • alkylating chemotherapy conditioning prior to stem cell transplantation combination of any alkylating agent with total body irradiation or whole abdomen or pelvic radiation cranial radiation ≥30 Gy summed alkylating agent dose score ≥3 (Green et al., 2009) cyclophosphamide equivalent dose (CED) ≥ 4,000 mg/m2 (Green et al., 2014)
Not Eligible

You will not qualify if you...

  • Patients with no anticipated oncologic therapies
  • Post-pubertal individuals
  • Pregnant children
  • Children with one ovary
  • Children deemed high risk for perioperative complications
  • Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ann & Robert H Lurie Childrens Hospital

Chicago, Illinois, United States, 60611

Actively Recruiting

Loading map...

Research Team

S

Sara Reyes

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here